TFEB and lysosomal storage disease: Studies performed in several lysosomal storage disorder (LSD) and neurodegenerative disease models suggest that enhancing both lysosomal and autophagic functions by overexpression/activation of Transcription Factor EB (TFEB) could be a more beneficial therapeutic approach 21,23–25.